In the original languageTranslation into English
Inguin-pelvic lymphodissection in the treatment of metastatic lesion of regional lymph nodes in vulva cancer
Authors
Polatova Djamila, Navruzova Visola
404
1
Share
404
1
Annotation
Knowledge of the prevalence of the cancer process and its microscopic signs helps to establish the stage of development of the disease helps to assess the likelihood of tumor recurrence and provides information that will allow the doctor to predict the therapeutic effect. In vulvar cancer, the tumor often spreads along the length and by metastasizing to regional lymph nodes (inguinal, femoral), and then to the pelvic lymph nodes. In malignant tumors, the level of lymph node damage, which can be determined by lymph node dissection, is of great importance for the choice of treatment method.
Keywords
lymph node dissection
lymphovascular invasive lesion.
Authors
Polatova Djamila, Navruzova Visola
404
1
Share
404
1
References:
- Hacker NF, Eifel PJ, van der Velden J. Cancer of the vulva. Int J Gynecol Obstet. 2015;131(Suppl 2):S76–S83.
- Hacker NF, Leuchter RS, Berek JS, Castaldo TW, Lagasse LD. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol. 1981;58:574–579.
- Levenback CF, Ali S, Coleman RL, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: A gynecologic oncology group study. J Clin Oncol. 2012;30:3786–3791.
- Robison K, Fiascone S, Moore R. Vulvar cancer and sentinel lymph nodes: a new standard of care? Expert Rev Anticancer Ther. 2014;14(9):975–977.
- Paladini D, Cross P, Lopes A, Monaghan JM. Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva. Cancer. 1994;74:2491–2496.
- Saito T, Tabata T, Ikushima H, et al. Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer. Int J Clin Oncol. 2018;23:201–234.
Other articles of the issue
